These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15242945)

  • 1. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.
    Martin V; Supanitsky A; Echeverria PC; Litwin S; Tanos T; De Roodt AR; Guarnera EA; Angel SO
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):704-10. PubMed ID: 15242945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.
    Picchio MS; Sánchez VR; Arcon N; Soto AS; Perrone Sibilia M; Aldirico MLA; Urrutia M; Moretta R; Fenoy IM; Goldman A; Martin V
    Exp Parasitol; 2018 Feb; 185():62-70. PubMed ID: 29309783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
    Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
    Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
    Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.
    Desolme B; Mévélec MN; Buzoni-Gatel D; Bout D
    Vaccine; 2000 May; 18(23):2512-21. PubMed ID: 10775785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.
    Vercammen M; Scorza T; Huygen K; De Braekeleer J; Diet R; Jacobs D; Saman E; Verschueren H
    Infect Immun; 2000 Jan; 68(1):38-45. PubMed ID: 10603366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
    Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
    Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.
    Li WS; Chen QX; Ye JX; Xie ZX; Chen J; Zhang LF
    Parasitol Res; 2011 Sep; 109(3):637-44. PubMed ID: 21404064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii.
    Leyva R; Hérion P; Saavedra R
    Parasitol Res; 2001 Jan; 87(1):70-9. PubMed ID: 11199854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
    Jongert E; de Craeye S; Dewit J; Huygen K
    Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
    Zhang G; Huong VT; Battur B; Zhou J; Zhang H; Liao M; Kawase O; Lee EG; Dautu G; Igarashi M; Nishikawa Y; Xuan X
    Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
    Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
    Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.
    Khosroshahi KH; Ghaffarifar F; Sharifi Z; D'Souza S; Dalimi A; Hassan ZM; Khoshzaban F
    Parasitol Res; 2012 Jul; 111(1):403-11. PubMed ID: 22350714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
    Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
    Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
    Wei QK; Li J; Fu TX; Bai XL; Cui Y; Zhang DB; Wang HF; Liu YB; Fu B; Zai DF; Huang BC; Liu KY; Han GD
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):337-41. PubMed ID: 17361811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis.
    Roque-Reséndiz JL; Rosales R; Herion P
    Parasitology; 2004 Apr; 128(Pt 4):397-405. PubMed ID: 15151145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.